The hydrogel microsphere vaccine induces a rocket-like cascade amplification of cDC1-mediated antigen cross-presentation and CD8+ T-cell activation, promoting the transformation of pancreatic cancer from “cold” to “hot” tumours in a safe and efficient manner (Fig. 1b, c). This evidence concerns the gene CD8A and familial pancreatic carcinoma.